Industry News
Hydrix wins Victorian enabling technology award
Hydrix, an engineering consultancy company operating in the medical device and other sectors, has won an award from the Victorian Manufacturing Hall of Fame. [ + ]
Registrations now open for the biotechnology event of the year, AusBiotech 2012
Returning to Melbourne this year, the biotechnology industry event of the year, AusBiotech 2012 national conference, is now open for registration. [ + ]
Immuron taps NZ dairy for colostrum production
Immuron (ASX:IMC) has signed a deal with dairy processing company Synlait covering the production of colostrum needed for its Travelan drug. [ + ]
IVD Australia welcomes scientist as Head of TGA
IVD Australia, the industry body representing manufacturers and sponsors of pathology tests, has congratulated Dr John Skerritt on his appointment as the new National Manager of the Therapeutic Goods Administration (TGA). [ + ]
Qiagen acquires AmniSure International, adds assay to Point of Need portfolio
Qiagen NV has announced the acquisition of AmniSure International LLC, a privately owned Boston company that markets the AmniSure assay for determining whether a pregnant woman is suffering rupture of foetal membranes (ROM), a condition in which fluid leaks from the amniotic sac prematurely. [ + ]
IQnovate to commercialise Nanosonics’ disinfection system
Contract medical company IQnovate (ASX:IQN) has signed an MoU with Sydney's Nanosonics to help commercialise an ultrasound disinfection system. [ + ]
Inspired by hackers: push for open source clinical trials
Clinical trials could be made more transparent, allowing greater sharing of knowledge and improved clinical outcomes, if they were modelled after the open source software movement, say researchers. [ + ]
Industry update from AusBiotech and PwC
AusBiotech’s CEO, Dr Anna Lavelle and PricewaterhouseCoopers’ (PwC) Partner, Craig Lawn, sat down to discuss the state of the biotechnology and life sciences sector on webcast, including the impact of the R&D Tax Credit, changes in the market for capital as well as current and emerging trends. [ + ]
Bioniche developing cancer products for dogs
Bioniche (ASX:BNC) is commercialising two products designed to treat cancer in man's best friend, including an immunotherapy for mammary cancer. [ + ]
Students win Australian finals of 2012 Imagine Cup with handheld digital stethoscope to detect pneumonia
A team of Victorian university students has invented a digital stethoscope that could help millions in the developing world by assisting in the early diagnosis of childhood pneumonia. The four students, known as ‘Team StethoCloud’, triumphed against four other teams to win the Australian finals of the 2012 Microsoft Imagine Cup challenge. [ + ]
Interacting light with matter - new tools for early cancer detection
A research team at the University of Adelaide, led by Professor Tanya Monro, is working to create a whole range of new high-tech tools that use light for measuring, including new devices for early detection of cancer and smart bungs that monitor wine quality. [ + ]
AtCor launches improved blood pressure test
AtCor Medical (ASX:ACG) has launched SphygmoCor XCEL, the newest iteration of its non-invasive central aortic blood pressure monitoring device. [ + ]
Osprey Medical completes $20m IPO
Shares in Osprey Medical (ASX:OSP), a US medical device company commercialising a product which uses Australian IP, began trading on the ASX on Wednesday. [ + ]
Australian researchers receive boost with IP reforms
Australian researchers now have the freedom to carry out research without the fear of being sued for patent infringement following the introduction of new laws, according to Parliamentary Secretary for Industry and Innovation Mark Dreyfus. [ + ]
Australian scientist using light to detect explosives
An Australian discovery has led to a portable new way to detect explosives using light-emitting molecules, offering an important tool to combat terrorism and remove land mines in war-torn countries. [ + ]

